Table 2.
Psychosocial measures in participants thoroughly screened and not thoroughly screened at baseline and follow-up.
| Scales | Baseline |
Follow-up |
||||
|---|---|---|---|---|---|---|
| Thoroughly screened n = 76 |
Not thoroughly screened n = 111 |
2 sided p-value | Thoroughly screened n = 53 |
Not thoroughly screened n = 73 |
2 sided p-value | |
| Median (range) | Median (range) (n) | Median (range) (n) | Median (range) (n) | |||
| HADS-A | 3.5 (0–15) | 4.0 (0–18) | 0.9 | 3 (0–14) | 4 (0–16) | 0.6 |
| HADS-D | 1 (0−20) | 2 (0–15) | 0.1 | 1 (0–19) | 2 (0−12) | 0.3 |
| STAI-6 | 23.3 (20–70) | 26.7 (20–80) | 0.6 | 23.3 (20–80) | 23.3 (20–63.7) | 0.6 |
| Negative emotional consequences PCQ | 0 (0–9) | 0 (0–8) | 0.5 | 0 (0−10) | 0 (0−11) | 0.8 |
| Negative physical consequences PCQ | 0 (0–5) | 0 (0–4) | 0.3 | 0 (0–8) | 0 (0–10) | 0.8 |
| Negative social consequences PCQ | 0 (0–8) | 0 (0–6) | 0.7 | 0 (0–7) | 0 (0–9) | 0.8 |
| Positive emotional consequences PCQ | 6 (0–15) | 4 (0–15) | 0.0002 | 7 (0–15) | 6 (0–15) | 0.6 |
| Positive physical consequences PCQ | 0 (0–9) | 0 (0–9) | 0.4 | 0 (0–9) | 0 (0–9) | 0.9 |
| Positive social consequences PCQ | 0 (0–6) | 0 (0–6) | 0.5 | 0 (0–6) | 0 (0–6) | 0.8 |
| SF-12 PCSa | 40.6 (30.9–47.3)⁎ | 40.5 (31.4–48.7) | 0.7 | 41.0 (4.0) | 40.4 (3.8) | 0.4 |
| SF-12 MCS | 49.3 (36.9–56.6)⁎ | 49.1 (28.5–60.5) | 0.4 | 49.2 (28.6–56.9) | 49.5 (35.5–59.2) | 0.02 |
n = 74 for SF-12 PCS and SF-12 MCS initial screening data of those thoroughly screened.